Collin Brummel

474 total citations
15 papers, 178 citations indexed

About

Collin Brummel is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Collin Brummel has authored 15 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Molecular Biology. Recurrent topics in Collin Brummel's work include Ethics in Clinical Research (4 papers), Head and Neck Cancer Studies (4 papers) and Cancer Genomics and Diagnostics (3 papers). Collin Brummel is often cited by papers focused on Ethics in Clinical Research (4 papers), Head and Neck Cancer Studies (4 papers) and Cancer Genomics and Diagnostics (3 papers). Collin Brummel collaborates with scholars based in United States. Collin Brummel's co-authors include J. Chad Brenner, Paul Swiecicki, Francis P. Worden, Emily L. Bellile, Andrew G. Shuman, Jonathan B. McHugh, Michelle Mierzwa, Matthew E. Spector, Catherine T. Haring and Kayte Spector‐Bagdady and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Collin Brummel

14 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Collin Brummel United States 9 71 58 56 43 39 15 178
Neil Mundi United States 10 75 1.1× 44 0.8× 73 1.3× 66 1.5× 35 0.9× 33 211
Miguel Pastor Borgoñón Spain 8 59 0.8× 21 0.4× 48 0.9× 57 1.3× 30 0.8× 13 144
Shen-Chih Chang United States 7 49 0.7× 27 0.5× 51 0.9× 59 1.4× 17 0.4× 7 200
Kalpana Devaraj United States 5 25 0.4× 26 0.4× 68 1.2× 64 1.5× 37 0.9× 9 216
Averdi Roezin Indonesia 2 117 1.6× 41 0.7× 54 1.0× 131 3.0× 33 0.8× 4 269
Yan-Fang Ye China 7 101 1.4× 28 0.5× 21 0.4× 76 1.8× 44 1.1× 7 167
Karin Annertz Sweden 7 208 2.9× 65 1.1× 92 1.6× 121 2.8× 48 1.2× 7 345
Diane Evrard France 7 34 0.5× 22 0.4× 45 0.8× 91 2.1× 47 1.2× 13 177
Umair Mahmood United States 7 89 1.3× 103 1.8× 44 0.8× 49 1.1× 72 1.8× 16 200
Osamu Fukuoka Japan 8 59 0.8× 31 0.5× 33 0.6× 74 1.7× 32 0.8× 18 332

Countries citing papers authored by Collin Brummel

Since Specialization
Citations

This map shows the geographic impact of Collin Brummel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Collin Brummel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Collin Brummel more than expected).

Fields of papers citing papers by Collin Brummel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Collin Brummel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Collin Brummel. The network helps show where Collin Brummel may publish in the future.

Co-authorship network of co-authors of Collin Brummel

This figure shows the co-authorship network connecting the top 25 collaborators of Collin Brummel. A scholar is included among the top collaborators of Collin Brummel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Collin Brummel. Collin Brummel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Dalal, Prarthana, Sarah M. Dermody, Collin Brummel, et al.. (2024). Clinical outcomes in salivary adenoid cystic carcinoma.. Journal of Clinical Oncology. 42(16_suppl). 6102–6102.
2.
Mann, Jacqueline E., Joshua D. Smith, Aditi Kulkarni, et al.. (2023). Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma. Oral Oncology. 146. 106562–106562. 9 indexed citations
3.
Haring, Catherine T., Sarah M. Dermody, Collin Brummel, et al.. (2023). Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols. Cancer. 129(18). 2817–2827. 32 indexed citations
4.
Bhambhani, Chandan, Erin Sandford, Catherine T. Haring, et al.. (2023). Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma. Oral Oncology. 143. 106436–106436. 8 indexed citations
5.
Spector‐Bagdady, Kayte, Chris Krenz, Collin Brummel, et al.. (2022). Patient and Provider Perspectives on Enrollment in Precision Oncology Research: Qualitative Ethical Analysis. JMIR Cancer. 8(2). e35033–e35033. 3 indexed citations
6.
Neal, Molly E. Heft, Collin Brummel, Jonathan B. McHugh, et al.. (2022). Analysis of Human Papilloma Virus Content and Integration in Mucoepidermoid Carcinoma. Viruses. 14(11). 2353–2353. 4 indexed citations
7.
Neal, Molly E. Heft, Aditi Kulkarni, Joshua D. Smith, et al.. (2021). Integrative sequencing discovers an ATF1-motif enriched molecular signature that differentiates hyalinizing clear cell carcinoma from mucoepidemoid carcinoma. Oral Oncology. 117. 105270–105270. 4 indexed citations
8.
Wang, Yifan, et al.. (2021). SearcHPV: A novel approach to identify and assemble human papillomavirus–host genomic integration events in cancer. Cancer. 127(19). 3531–3540. 11 indexed citations
9.
Haring, Catherine T., Chandan Bhambhani, Collin Brummel, et al.. (2021). Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma. Oncotarget. 12(13). 1214–1229. 44 indexed citations
10.
Lutz, Eric R., Lakshmi Rudraraju, Daniela A. Bota, et al.. (2020). 154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors. SHILAP Revista de lepidopterología. A93.1–A93. 1 indexed citations
11.
Swiecicki, Paul, Emily L. Bellile, Collin Brummel, J. Chad Brenner, & Francis P. Worden. (2020). Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteria. Cancer. 127(2). 219–228. 23 indexed citations
12.
Brummel, Collin, Timothy J. Geddes, George D. Wilson, et al.. (2020). Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma. Head & Neck. 43(2). 544–557. 16 indexed citations
13.
Spector‐Bagdady, Kayte, Chris Krenz, Collin Brummel, et al.. (2020). “My Research Is Their Business, but I'm Not Their Business”: Patient and Clinician Perspectives on Commercialization of Precision Oncology Data. The Oncologist. 25(7). 620–626. 12 indexed citations
14.
Shuman, Andrew G., Michele C. Gornick, Collin Brummel, et al.. (2019). Patient and Provider Perspectives Regarding Enrollment in Head and Neck Cancer Research. Otolaryngology. 162(1). 73–78. 10 indexed citations
15.
Spector‐Bagdady, Kayte, Chris Krenz, Collin Brummel, et al.. (2019). 3313 “My research is their business, but I’m not their business”: Patient and Oncologist Perspectives on the Commercialization of Research Data. SHILAP Revista de lepidopterología. 3(s1). 136–136. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026